NWBI:NASDAQNorthwest Bancshares, Inc. Analysis
Data as of 2026-04-21 - not real-time
$13.36
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
NWBI is trading at $13.36, comfortably above its 20‑day SMA (13.08) and 50‑day SMA (12.79), while the 200‑day SMA sits at 12.49, confirming a bullish alignment. The RSI 60.6 and a bullish MACD histogram (+0.01) reinforce upward momentum, though the stock is approaching the 52‑week resistance of $13.75 with decreasing volume, suggesting limited short‑term upside. Volatility over the past 30 days is moderate at 15%, and a beta of 0.78 indicates lower sensitivity to market swings. Valuation metrics show a trailing P/E 14.5 versus the industry average of 17.7 and a forward P/E of 9.4, indicating the stock is priced fairly or slightly below peers. The dividend yield 5.98% is attractive, but a payout ratio of 87% raises questions about sustainability. The Fear & Greed Index at 86 reflects extreme market optimism, which could compress future upside.
Revenue surged 25% YoY, and operating margins are strong at 40%, delivering a profit margin of 21% and an ROE of 7.2%, underscoring solid earnings quality. Recent analyst commentary upgraded the stock to “Hold” after a strong Q4 2025 performance and improving asset quality, and the company will present Q1 2026 results on April 27, providing a catalyst for re‑evaluation. The DCF fair‑value estimate of $23.85 suggests considerable long‑term upside beyond the current price. However, free cash flow is currently zero, and the high dividend payout may limit cash flexibility. With a modest max drawdown of 16.5% and a stable regional footprint across four states, geographic and regulatory risks remain low to medium. Overall, the blend of bullish technicals, reasonable valuation, and strong dividend income makes NWBI a compelling candidate for investors with a medium‑ to long‑term horizon, provided they monitor dividend sustainability and upcoming earnings.
Revenue surged 25% YoY, and operating margins are strong at 40%, delivering a profit margin of 21% and an ROE of 7.2%, underscoring solid earnings quality. Recent analyst commentary upgraded the stock to “Hold” after a strong Q4 2025 performance and improving asset quality, and the company will present Q1 2026 results on April 27, providing a catalyst for re‑evaluation. The DCF fair‑value estimate of $23.85 suggests considerable long‑term upside beyond the current price. However, free cash flow is currently zero, and the high dividend payout may limit cash flexibility. With a modest max drawdown of 16.5% and a stable regional footprint across four states, geographic and regulatory risks remain low to medium. Overall, the blend of bullish technicals, reasonable valuation, and strong dividend income makes NWBI a compelling candidate for investors with a medium‑ to long‑term horizon, provided they monitor dividend sustainability and upcoming earnings.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Near 52‑week resistance at $13.75
- Decreasing volume signals waning momentum
- Upcoming Q1 earnings may cause volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong 25% revenue growth
- Attractive 5.98% dividend yield
- Fair valuation relative to peers (P/E 14.5 vs 17.7)
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value indicates upside
- Stable regional presence across four states
- Consistent dividend income despite high payout
Key Metrics & Analysis
Financial Health
Revenue Growth25.10%
Profit Margin21.03%
P/E Ratio14.5
ROE7.23%
ROA0.81%
P/B Ratio1.0
Op. Cash Flow$153.4M
Industry P/E17.7
Technical Analysis
TrendBullish
RSI60.6
Support$12.30
Resistance$13.75
MA 20$13.08
MA 50$12.79
MA 200$12.49
MACDBullish
VolumeDecreasing
Fear & Greed Index86.2
Valuation
Fair Value$23.85
Target Price$13.86
Upside/Downside3.76%
GradeFair
TypeBlend
Dividend Yield5.98%
Risk Assessment
Beta0.78
Volatility15.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.